Akihiro Kobayashi
President at KOBAYASHI PHARMACEUTICAL CO., LTD.
Net worth: 312 M $ as of 2024-03-30
Profile
Akihiro Kobayashi occupies the position of President & Representative Director at Kobayashi Pharmaceutical Co., Ltd. Mr. Kobayashi is also on the board of Medicon, Inc. (Japan).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 9,264,000 ( 11.87% ) | 312 M $ | 2024-03-30 |
Akihiro Kobayashi active positions
| Companies | Position | Start |
|---|---|---|
| KOBAYASHI PHARMACEUTICAL CO., LTD. | President | 2013-05-31 |
Medicon, Inc. (Japan)
 Medicon, Inc. (Japan) Medical SpecialtiesHealth Technology Medicon, Inc. (Japan) manufactures, imports and sells medical equipment. It offers products related to the following: urination care, end yuro biology, critical care, catheter fixed, radiation therapy, interactive voice response (IVR), biopsy, hernia surgery, surgery, percutaneous endoscopic gastronomy (PEG), intravenous nutrition and chemotherapy, and dialysis. The company was founded on June 2, 1972 and is headquartered in Osaka City. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KOBAYASHI PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Medicon, Inc. (Japan)
Medicon, Inc. (Japan) Medical SpecialtiesHealth Technology Medicon, Inc. (Japan) manufactures, imports and sells medical equipment. It offers products related to the following: urination care, end yuro biology, critical care, catheter fixed, radiation therapy, interactive voice response (IVR), biopsy, hernia surgery, surgery, percutaneous endoscopic gastronomy (PEG), intravenous nutrition and chemotherapy, and dialysis. The company was founded on June 2, 1972 and is headquartered in Osaka City. | Health Technology |
- Stock Market
- Insiders
- Akihiro Kobayashi
